MBCBrainmets.org
  • Learn
    • Brain Metastasis
      • About Brain Metastasis
      • Treatments
    • Leptomeningeal Disease
      • About Leptomeningeal Disease
      • Treatments
    • Dig Deeper
      • Central Nervous System
      • Second Opinions
  • Engage
    • Patient Videos
    • Patient Blogs
    • Experts Corner
    • Our Story
    • About Us
  • Explore
    • Find a Second Opinion
    • Research
    • Resources & Support
    • Webinars & Podcasts
    • FAQs
  • Trials
    • Clinical Trials 101
    • Find a Clinical Trial
    • Featured Clinical Trials
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu

Radiosensitizers

October 21, 2021
« Back to Glossary Index

Is a drug that makes cancer cells more vulnerable to radiation therapy.

« Back to Glossary Index
Share this entry
  • Share on Facebook
  • Share on X
  • Share on WhatsApp
  • Share on LinkedIn
  • Share on Reddit
  • Share by Mail
https://mbcbrainmets.org/wp-content/uploads/2021/10/brain-mets-logo-2.png 0 0 Patti Meyer https://mbcbrainmets.org/wp-content/uploads/2021/10/brain-mets-logo-2.png Patti Meyer2021-10-21 22:03:262021-10-21 22:03:26Radiosensitizers
MBCBrainMets.org

As a one-stop resource hub for breast cancer patients living with brain metastasis, we are committed to sharing cutting-edge information and resources in a simple format. Curated by fellow patients and supported by nonprofit funding, our mission is to connect you to knowledge and support tailored specifically to your needs.

Learn

  • Brain Metastasis
  • Leptomeningeal Disease
  • Treatments- Brain Metastasis
  • Treatments- Leptomeningeal Disease
  • Find a Second Opinion

Resources

  • Clinical Trials
  • FAQs
  • Glossary
  • Privacy Policy
  • Copyright Notice
© Copyright - MBCBrainmets.org | Site by Dot Think
Link to: Radiation therapy Link to: Radiation therapy Radiation therapy Link to: Standard Of Care Link to: Standard Of Care Standard Of Care
Scroll to top Scroll to top Scroll to top

Sign Up for Our Quarterly Newsletter

Keep up to date on new research, clinical trials and more.